VitaNova Life Sciences (VNOV) Change in Account Payables (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Change in Account Payables came in at $99835.0 in Q2 2026, up 2023.6% YoY from $4701.2 in Q2 2025, and up 267.87% on a QoQ basis from -$59472.0 in Q1 2026.
VitaNova Life Sciences (VNOV) Change in Account Payables (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 3 years of Change in Account Payables data on file, last reported at $99835.0 in Q2 2026.
- Quarterly Change in Account Payables rose 2023.6% year-over-year to $99835.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $35173.0 (changed N/A YoY) and the FY2026 annual result came in at $208813.0, up 4123.37% from the prior year.
- Change in Account Payables grew to $99835.0 in Q2 2026, from -$59472.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $99835.0 in Q2 2026 to a low of -$59472.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 3.77 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 2.83 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 450.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | - |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -586,000.00 |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -2.00 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 99,835.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 99,835.00 |
| Apr 30, 2026 | 99,835.00 |
| Jan 31, 2026 | -59,472.00 |
| Jan 31, 2026 | -59,472.00 |
| Apr 30, 2025 | -5,190.00 |
| Apr 30, 2025 | -5,190.00 |
| Oct 31, 2017 | -6,000.00 |
| Oct 31, 2017 | -6,000.00 |